Helvy
Early access is openJoin the list
Metabolic
In the UK, the standard clinical (NHS) reference range for Omega-3 Index (EPA + DHA) is 4-8%, with 8-12% considered the performance-optimised range. A result within these ranges suggests typical status; only a qualified clinician can interpret an individual reading.
The Omega-3 Index measures the percentage of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in your red blood cell membranes, expressed as a proportion of total fatty acids. Because red blood cells have a lifespan of approximately 120 days, this test reflects your average omega-3 status over the previous 3-4 months — far more reliable than a snapshot of plasma levels or a dietary recall questionnaire. The test was first proposed as a standardised risk factor in 2004 and has since been validated in over 40 prospective studies linking it to cardiovascular, cognitive, and inflammatory outcomes.
Optimal range · UK
8-12%
Performance-optimised band · clinical (NHS) range 4-8%
Reference ranges for Omega-3 Index, not a personal result. Any individual reading should be interpreted by a qualified clinician.
Optimal ranges
| Range | Value |
|---|---|
| Clinical (NHS) reference range | 4-8% |
| Performance-optimised range | 8-12% |
The clinical range defines what is considered medically “normal” — broad enough to cover 95% of the population. The performance range reflects where research and clinical experience suggest most people feel and function at their best. A result in either range suggests typical status and is not a diagnosis; any individual reading should be interpreted by a qualified clinician.
Why it matters
The Omega-3 Index is emerging as one of the most actionable biomarkers in preventive health. A 2018 meta-analysis in the Journal of Clinical Lipidology found that individuals with an Omega-3 Index above 8% had a 35% lower risk of fatal coronary heart disease compared to those below 4%. For active men, omega-3s are critical beyond heart health — EPA and DHA reduce exercise-induced inflammation, support joint integrity under load, and improve muscle protein synthesis when combined with resistance training. DHA alone constitutes roughly 40% of the polyunsaturated fatty acids in the brain, making it essential for focus, mood, and cognitive performance under stress. Most people in the UK sit between 4-6%, well below the protective threshold. Unlike many biomarkers where 'normal' ranges are reassuringly wide, the Omega-3 Index has a clear dose-response relationship: higher is better, up to about 12%.
Symptoms
Low / Deficiency
High / Excess
Dietary sources
Supplementation
Fish oil providing 2-4g combined EPA+DHA daily is the most evidence-based approach to raising the Omega-3 Index. Look for triglyceride-form fish oil over ethyl ester — it has approximately 70% better absorption. Take with a fat-containing meal for optimal uptake. Most people starting below 6% will need 8-12 weeks of consistent supplementation to reach the 8% threshold. Algal oil (providing DHA and increasingly EPA) is the primary plant-based alternative, though achieving the same EPA dose as fish oil requires higher volumes. Krill oil is another option — its phospholipid-bound omega-3s may absorb slightly better, but capsules typically contain lower total EPA+DHA per serving, making it more expensive per gram. Cod liver oil is not recommended as a primary source due to the risk of excessive vitamin A intake at the doses needed to deliver meaningful EPA+DHA. Retest at 90-120 days to confirm your index has reached the protective range.
Testing
Omega-3 Index is measured from a blood sample. With Helvy, that means a finger-prick kit taken at home and posted to a UKAS-accredited UK laboratory, with results in around 5 days, reviewed by a qualified clinician. Your result is reported against both the clinical range (4-8%) and the performance-optimal range (8-12%), so you can see not just whether you are “normal” but whether you are optimal. If you make a change, retest after 8-12 weeks to confirm it worked.
Research
The Omega-3 Index: a new risk factor for death from coronary heart disease?
Harris WS, Von Schacky C
Preventive Medicine (2004)
DOI: 10.1016/j.ypmed.2004.02.030Related biomarkers
Related guides
This content is for educational purposes only and does not constitute medical advice. Your data suggests areas for optimisation, but any concerns should be discussed with a qualified healthcare professional. If your results flag values outside safe ranges, we recommend consulting your GP.
Your next step